Development of analytical strategies in combinatorial processes used in drug discovery

Project Information

Grant agreement ID: HPMI-CT-1999-00021

Project closed

Start date 1 February 2000

End date 31 January 2004

Funded under

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Total cost € 423 360,00

EU contribution € 423 360,00

Coordinated by

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
United Kingdom

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery

Programme(s)

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Topic(s)

Data not available

Call for proposal

Data not available

Funding Scheme

BUR - Bursaries, grants, fellowships

Coordinator

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED

• EU contribution: No data
• Address: Glaxo Willcome House, Berkeley Avenue, Greenford ; UB6 ONN UXBRIDGE ; United Kingdom
• Total cost: No data